CG 우리 카지노 Signs Strategic Partnership with Health On Cloud to Expand Global Genomics and CRO Business

[by Ji, Yong Jun] CG 우리 카지노, a company specializing in digital genome-based new drug development, announced on January 15 that it has signed a business agreement with Health On Cloud (hereinafter referred to as HOC) to expand its network and enter new international markets, focusing on genome-related and clinical trial contract research (CRO) services.

The agreement was formalized at the 우리 카지노 Ecosystem headquarters in Magok-dong, Gangseo District, Seoul, with the presence of Shin Yong-gyu, Chairman of 우리 카지노 Ecosystem, Jung In-cheol, CEO of CG 우리 카지노, Professor Jheon Sang-hoon of Seoul National University Bundang Hospital and founder of HOC, and Park Eok-sung, CEO of HOC.

Since joining the 우리 카지노 Ecosystem, which seeks to build a comprehensive value chain in personalized health and disease management, CG 우리 카지노 has been offering innovative healthcare solutions that go beyond traditional new drug development methods. These solutions combine genomic analysis, artificial intelligence (AI), and bioinformatics. The company is also actively working to acquire overseas hospitals with the goal of developing and entering new markets.

HOC, established by veteran specialists w우리 카지노h decades of medical expertise, runs Curisall, a remote medical treatment platform, and Medtis, a remote medical education platform.

우리 카지노 boasts a robust network centered on the healthcare ecosystem in Latin America, including Colombia, Mexico, and Brazil. Add우리 카지노ionally, 우리 카지노 is part of the SHA (Smart Hosp우리 카지노al Alliance) network, which connects prominent medical professionals around the world. The SHA network includes leading Korean univers우리 카지노y hosp우리 카지노als and over 30 large hosp우리 카지노als across nine countries, such as the U.S., UK, Singapore, Colombia, and UAE.

CG 우리 카지노 expects that its partnership with HOC, which has an extensive global medical network, will expedite its expansion into new international markets such as Latin America and the Middle East. This will be driven by CG 우리 카지노’ digital genome and CRO businesses, which it is actively developing.

“We anticipate that the healthcare businesses we are currently pursuing will gain wider recognition in new overseas markets, such as Latin America and the Middle East, through HOC’s digital medical platform,” Jung stated. “This collaboration will help achieve the 우리 카지노 Ecosystem’s goal, Beyond Healthcare, more quickly.”